logo
What's Driving You Crazy? – Another complete closure of the 215 beltway in the southwest valley

What's Driving You Crazy? – Another complete closure of the 215 beltway in the southwest valley

Yahoo14-05-2025

LAS VEGAS ( KLAS ) – We could talk about it all day every day, and still, thousands of people will be caught off guard again this weekend when both directions of the 215 southwestern beltway will close between Flamingo and Tropicana.
In June of last year Clark County started a year-long project to build a bridge connecting Peace Way from Ft Apache west of the beltway to a little street called Chessie Ct a few blocks west of El Capitan.
The first full closure back in December lasted a whole weekend.
The second one in February was 'just' 24 hours, and that's what Clark County says will be the case again this weekend, meaning you should probably avoid the area from 9 Friday night to 9 Saturday night,
Workarounds? You can get on the northbound beltway from Flamingo just west of Ft Apache, and southbound from Tropicana just east of Ft Apache.
All lanes in both directions should be back open by 10 Saturday night.
The $20 million dollar project also includes other work on Peace Way between Hualapai and Cimarron.
To learn more about the project, click – – – > HERE.
And while we're talking weekend traffic nightmares, don't forget tens of thousands of people heading to the Las Vegas Motor Speedway on Friday, Saturday and Sunday night – then sliding back down into the city in sunrise hours each following morning for this year's Electric Daisy Carnival.
Buckle up, drive carefully – and, please put down that phone!
You're welcome join the 'Driving You Crazy' conversation: traffic8@8newsnow.com.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Virginia governor candidates vow to end 'car tax'
Virginia governor candidates vow to end 'car tax'

Yahoo

time2 hours ago

  • Yahoo

Virginia governor candidates vow to end 'car tax'

PORTSMOUTH, Va. (WAVY) — Virginia's car tax is widely considered the most-hated tax in the state, and it could be coming to an end soon. Both candidates for the Virginia governor's race have expressed their desire to eliminate the state's car tax. Republican Lt. Gov Winsome Earle-Sears recently announced her 'Axe the Tax' initiative, which would end the state's car tax as well as income taxes on tipped wages. A campaign spokesperson for Democrat Abigail Spanberger said, 'Abigail will work with both Democrats and Republicans to put Virginia on a real path towards eliminating the car tax once and for all.' However, the state estimates an elimination of the state's car tax would cost localities around 2.5 to 3 billion a year, a price some state lawmakers are concerned about. 'You got to wrestle through a way to deal with that. That doesn't leave the localities holding the bag because it's localities who pick up most of the cost. For example, your local police department or your local school divisions,' said Sen. Mark Warner. In a statement sent to 10 On Your side, Sen Tim Kaine said, 'This is a complicated issue that requires delicate balancing, and it's ultimately up to the General Assembly to make changes to the state tax code.' Despite the hefty price, some residents in the Hampton Roads area are still in favor of eliminating the tax. 'I most certainly am in favor of whichever candidate wins to stop, to eliminate, to get rid of the personal property taxes on our cars. There's other avenues, where a city can bring in that extra money so, I would say let's end it and go from there,' said Portsmouth resident Michael Crowell. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Repairs begin on Blue Bridge in Owensboro
Repairs begin on Blue Bridge in Owensboro

Yahoo

time4 hours ago

  • Yahoo

Repairs begin on Blue Bridge in Owensboro

OWENSBORO, Ky. (WEHT) — Lane restrictions are underway on the Blue Bridge in Owensboro. This is the first phase of repairs that are set to begin after the fourth of July holiday weekend. Currently one lane of Kentucky 2262 will remain open during this initial part of the work which will include flaggers directing alternating one-lane traffic. After the 4th of July the bridge will be completely closed for 90 days this summer. During the closure crews will replace the aging bridge deck, make concrete repairs and repair bridge joints. Officials say only closing one lane at a time is impossible, requiring the bridge to close completely. The repairs will allow for long-term concrete maintenance to be completed helping to keep the bridge safe and open for years to come. The lane restrictions should end June 12th before being closed for 90 days. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James
Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James

Yahoo

time5 hours ago

  • Yahoo

Avidity Biosciences, Inc. (RNA) Initiated with a Strong Buy at Raymond James

Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the 13 Biotech Stocks with Huge Upside Potential. Raymond James has started coverage of Avidity Biosciences, Inc. (NASDAQ:RNA), with a Strong Buy rating and a price objective of $65. A scientist holding a vial of a promising product candidate for therapeutic development. The rating is part of a larger biotech sector note, in which the firm sees favorable risk/reward across the board. Raymond James points out that less de-risked platforms can produce the most outsized returns, even if companies with de-risked, high probability-of-success assets are frequently viewed with greater certainty. The firm stresses its confidence in del-zota, which is anticipated to be the first medicine from Avidity Biosciences, Inc. (NASDAQ:RNA)'s antibody oligonucleotide conjugate (AOC) platform to be approved. Avidity Biosciences, Inc. (NASDAQ:RNA) is becoming more well-known for its AOC platform, which targets muscle disorders by combining oligonucleotides and antibodies. According to Raymond James, one of the platform's top candidates, Del-Zota, has a strong chance of being approved. The $65 objective is in line with the firm's opinion that early-stage, less-risked assets can yield higher returns and points out faith in the platform's revolutionary potential. Avidity Biosciences, Inc. (NASDAQ:RNA) is a biopharmaceutical firm dedicated to developing a novel type of RNA treatment known as Antibody Oligonucleotide Conjugates, or AOCs. While we acknowledge the potential of RNA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025. Disclosure. None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store